Cargando…
COVID‐19 vaccine (ChAdOx1 nCoV‐19 Corona virus vaccine (Recombinant) – COVISHIELD related MS relapse
BACKGROUND: there are very few reports of COVID-19 vaccine related multiple sclerosis (MS) relapses. Here we report our first case of ChAdOx1 nCoV-19 Corona virus vaccine related MS relapse. CASE PRESENTATION: a 24- year- old lady doctor, who had taken ChAdOx1 nCoV-19 Corona virus vaccine got a rela...
Autores principales: | Mathew, Thomas, John, Saji K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285929/ http://dx.doi.org/10.1016/j.nerep.2021.100006 |
Ejemplares similares
-
Impact of ChAdOx1 nCoV-19 (Covishield™) Vaccination: How Long Will It Persist?
por: Devi, Leimapokpam Sumitra, et al.
Publicado: (2022) -
Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona
virus vaccine: ultrasound findings and clinical implications
por: Sahoo, Soumya Swaroop, et al.
Publicado: (2022) -
Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine
por: Sivaramakrishnan, Prakash, et al.
Publicado: (2022) -
Serological immune response following ChAdOx1 nCoV-19 vaccine (Covishield) in patients with liver cirrhosis
por: Katiyar, Harshita, et al.
Publicado: (2022) -
Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield(®)) in Patients with Liver Cirrhosis
por: Goel, Amit, et al.
Publicado: (2022)